Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-20-014522
Filing Date
2020-12-10
Accepted
2020-12-10 16:42:56
Documents
2
Period of Report
2020-12-03

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 1482
2 poawest.txt EX-24 3045
  Complete submission text file 0001225208-20-014522.txt   5807
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1915 REXFORD ROAD CHARLOTTE NC 28211
Business Address
West Nadja (Reporting) CIK: 0001787802 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-03215 | Film No.: 201381124